Canopy Growth (CGC) Return on Capital Employed (2020 - 2025)
Canopy Growth's (CGC) quarterly Return on Capital Employed came in at 12.43% in Q4 2025, up 4408.0% year-on-year from 0.28% in Q4 2024, and up 6.26% quarter-over-quarter from 13.26% in Q3 2025.
Canopy Growth (CGC) Return on Capital Employed (2020 - 2025) Analysis & Trends
Canopy Growth has disclosed Return on Capital Employed across 6 years of filings, most recently posting 12.43% for Q4 2025.
- Return on Capital Employed for Q4 2025 came in at 12.43%, up 4408.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 12.43% (up 4408.0% YoY), and the FY2025 annual result was 14.97%, down 95.0% from the prior year.
- Return on Capital Employed came in at 12.43% for Q4 2025 at Canopy Growth, up from 13.26% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 1.37% in Q1 2022 to a low of 147.1% in Q1 2023.
- The 5-year median for Return on Capital Employed is 22.16% (2024), against an average of 35.61%.
- Across the five-year window, Return on Capital Employed sank 14574 bps in 2023 and soared 12613 bps in 2024, its largest moves.
- Canopy Growth's Return on Capital Employed stood at 12.82% in 2021, then tumbled by 431 bps to 68.03% in 2022, then gained by 24 bps to 51.43% in 2023, then retreated by 10 bps to 56.51% in 2024, then soared by 78 bps to 12.43% in 2025.
- The last three Return on Capital Employed figures came in at 12.43% (Q4 2025), 13.26% (Q3 2025), and 18.85% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | -12.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.43% |
| Sep 30, 2025 | -13.26% |
| Jun 30, 2025 | -18.85% |
| Mar 31, 2025 | -23.35% |
| Dec 31, 2024 | -56.51% |
| Sep 30, 2024 | -24.94% |
| Jun 30, 2024 | -18.06% |
| Mar 31, 2024 | -20.98% |
| Dec 31, 2023 | -51.43% |
| Sep 30, 2023 | -41.20% |
| Jun 30, 2023 | -46.39% |
| Mar 31, 2023 | -147.10% |
| Dec 31, 2022 | -68.03% |
| Sep 30, 2022 | -58.51% |
| Jun 30, 2022 | -41.43% |
| Mar 31, 2022 | -1.37% |
| Dec 31, 2021 | -12.82% |
| Sep 30, 2021 | -17.92% |
| Jun 30, 2021 | -18.32% |
| Mar 31, 2021 | -19.35% |